UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Endocrine reviews, 2005-08, Vol.26 (5), p.688-703

2005

Volltextzugriff (PDF)

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Volltextzugriff (PDF)

Effects Of a One‐Month Treatment With PTH(1–34) on Bone Formation on Cancellous, Endocortical, and Periosteal Surfaces of the Human Ilium

Journal of bone and mineral research, 2007-04, Vol.22 (4), p.495-502

2007

Volltextzugriff (PDF)

Fracture risk in kidney transplant recipients: a systematic review

Transplantation, 2013-06, Vol.95 (12), p.1461-1470

2013

Volltextzugriff (PDF)

Trabecular bone score in kidney transplant recipients

Osteoporosis international, 2016-03, Vol.27 (3), p.1115-1121

2016

Volltextzugriff (PDF)

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Osteoporosis international, 2009-01, Vol.20 (1), p.1-21

2009

Volltextzugriff (PDF)

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2003-11, Vol.88 (11), p.5212-5220

2003

Volltextzugriff (PDF)

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4528-4535

2002

Volltextzugriff (PDF)

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Volltextzugriff (PDF)

Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment

Clinical Therapeutics, 2004, Vol.26 (1), p.15-28

2004

Volltextzugriff (PDF)

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Bone (New York, N.Y.), 2000-08, Vol.27 (2), p.311-318

2000

Volltextzugriff (PDF)

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.620-628

1997

Volltextzugriff (PDF)

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Journal of bone and mineral research, 2000-06, Vol.15 (6), p.1033-1044

2000

Volltextzugriff (PDF)

Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date

Canadian Medical Association journal (CMAJ), 2002-05, Vol.166 (11), p.1426

2002

Volltextzugriff (PDF)

The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride

The journal of clinical endocrinology and metabolism, 1989-11, Vol.69 (5), p.932-938

1989

Volltextzugriff (PDF)

Management of corticosteroid-induced osteoporosis

Seminars in arthritis and rheumatism, 2000-02, Vol.29 (4), p.228-251

2000

Volltextzugriff (PDF)

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Bone (New York, N.Y.), 2000-03, Vol.26 (3), p.221-225

2000

Volltextzugriff (PDF)

Expression of PTH1R constructs in LLC-PK1 cells: Protein nuclear targeting is mediated by the PTH1R NLS

Bone (New York, N.Y.), 2007-10, Vol.41 (4), p.603-610

2007

Volltextzugriff (PDF)

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Journal of allergy and clinical immunology, 1995-08, Vol.96 (2), p.157-166

1995

Volltextzugriff (PDF)

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

The Journal of clinical investigation, 1993-03, Vol.91 (3), p.1138-1148

1993

Volltextzugriff (PDF)

Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?

Peritoneal dialysis international, 2001-01, Vol.21 Suppl 3 (3_suppl), p.S247-255

Hodsman, A B

2001

Volltextzugriff (PDF)

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Bone (New York, N.Y.), 1993, Vol.14 (3), p.523-527

1993

Volltextzugriff (PDF)

Preliminary observations of a form of coherence therapy for osteoporosis

Calcified tissue international, 1984-12, Vol.36 (3), p.341-343

1984

Volltextzugriff (PDF)

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

The journal of clinical endocrinology and metabolism, 1999-08, Vol.84 (8), p.2739-2743

1999

Volltextzugriff (PDF)

Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat

Bone (New York, N.Y.), 1999-02, Vol.24 (2), p.89-94

1999

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(74)
Deutsch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Humans
(60)
Biological And Medical Sciences
(50)
Female
(48)
Medical Sciences
(41)
Endocrinology & Metabolism
(34)
Middle Aged
(32)
Male
(31)
Pharmacology. Drug Treatments
(24)
Aged
(23)
Adult
(19)
Osteoporosis
(19)
Bone Density
(13)
Animals
(12)
Bone Density - Drug Effects
(12)
Rats
(12)
Bones, Joints And Connective Tissue. Antiinflammatory Agents
(11)
Osteoporosis, Postmenopausal - Drug Therapy
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Effects Of a One‐Month Treatment With PTH(1–34) on Bone Formation on Cancellous, Endocortical, and Periosteal Surfaces of the Human Ilium

Fracture risk in kidney transplant recipients: a systematic review

Trabecular bone score in kidney transplant recipients

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date

The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride

Management of corticosteroid-induced osteoporosis

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Expression of PTH1R constructs in LLC-PK1 cells: Protein nuclear targeting is mediated by the PTH1R NLS

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Preliminary observations of a form of coherence therapy for osteoporosis

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat

Suchergebnisse filtern